Alvotech, SIMLANDI, Adalimumab, Adalimumab-ryvk, Humira Biosimilar, Biosimilars, Interchangeable Biosimilar, FDA, FDA Approval, Biologics, Pharmaceutical Manufacturing

Reykjavik, Iceland, October 5, 2026 Alvotech has announced that the U.S. Food and Drug Administration (FDA) has approved additional...